UK Markets open in 5 hrs 34 mins

Grifols, S.A. (0RDV.IL)

IOB - IOB Delayed price. Currency in EUR
Add to watchlist
13.16-0.02 (-0.15%)
At close: 5:22PM BST
Full screen
Previous close13.18
Open13.24
Bid12.88 x 0
Ask13.43 x 0
Day's range13.24 - 13.29
52-week range11.90 - 16.90
Volume9,894
Avg. volume27,227
Market capN/A
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Bloomberg

    Grifols Buys Biotest as Creat Pushed to Exit Blood-Plasma Stakes

    (Bloomberg) -- Grifols SA agreed to buy Biotest AG for about 1.6 billion euros ($1.9 billion), pouncing after U.S. regulators pushed back on Chinese shareholder Creat Group Corp.’s expansion into the blood-plasma industry.Grifols offered 43 euros for each ordinary share and 37 euros for each preferred share, the Spanish company said Friday. That’s 23% and 4.2% higher than Thursday’s closing prices, respectively. Bloomberg News reported late Thursday that the deal was imminent.Creat’s strategy to

  • Reuters

    Spain's Grifols to buy rival Biotest for up to $1.9 billion

    MADRID (Reuters) -Spanish pharmaceuticals company Grifols proposed a 1.6 billion euro ($1.9 billion) takeover of its German rival Biotest on Friday, in a move to consolidate the plasma-based drug industry. Grifols said it had agreed with Tiancheng International Investment to buy the Hong Kong-based company's controlling stake in Biotest for 1.1 billion euros. The Barcelona-based company agreed to buy 89.88% of Biotest's ordinary shares that carry voting rights, but which represent only 44.54% of the company's capital, and a further 0.54% of capital in preferred shares that do not carry voting rights, from Hong Kong-based Tiancheng.